SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Nanduru Anil

(Last) (First) (Middle)
C/O GENPACT LLC
521 FIFTH AVENUE, 14TH FLOOR

(Street)
NEW YORK NY 10175

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/29/2024
3. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 66,454(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) (2) 02/18/2030 Common Shares 107,981 43.94 D
Employee Stock Option (Right to Buy) (3) 03/03/2031 Common Shares 74,101 39.97 D
Employee Stock Option (Right to Buy) (4) 01/09/2032 Common Shares 62,047 52.12 D
Explanation of Responses:
1. Includes (i) 4,737 unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the "Plan"), of which 50% will vest on January 10, 2025 and the remaining 50% will vest on January 10, 2026, subject to the reporting person's continued service through each vesting date, (ii) 24,349 shares underlying performance share units (PSUs) granted under the Plan on March 20, 2022, and (iii) 1,621 shares acquired under the Genpact Employee Stock Purchase Plan. The PSU grant was subject to performance conditions which have been satisfied, and each PSU and RSU represents the contingent right to receive one common share. The 2022 PSU grant will vest on January 10, 2025, subject to the reporting person's continued service through such date.
2. The option vested 50% on February 19, 2023 and the remaining 50% will vest on February 19, 2025, subject to the reporting person's continued service through such date.
3. The option vested 50% on January 10, 2024 and the remaining 50% will vest on January 10, 2026, subject to the reporting person's continued service through such date.
4. The option vests 50% on January 10, 2025 and 50% on January 10, 2027, subject to the reporting person's continued service through each vesting date.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Thomas D. Scholtes, as Attorney-in-fact for Anil Nanduru 03/11/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
powerofattorney-nandurux
POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that the undersigned hereby constitutes, designates and appoints Heather D. White, Thomas D. Scholtes and any attorney of Wilmer Cutler Pickering Hale and Dorr LLP, and each of them, as such person’s true and lawful attorneys-in-fact and agents, with full power of substitution, for the undersigned and in the undersigned’s name, place and stead, in any and all capacities, to execute, acknowledge, deliver and file any and all documents required by the Securities and Exchange Act of 1934, as amended, including Section 16 of such act, and the rules and regulations thereunder, and requisite documents in connection with such filings, respecting securities of Genpact Limited, a Bermuda company, including but not limited to Forms 3, 4 and 5 under such act and any amendments thereto. This Power of Attorney shall be valid from the date hereof until revoked by the undersigned. IN WITNESS WHEREOF, the undersigned has executed the instrument effective as of this 6th day of March, 2024. /s/ Anil Nanduru Anil Nanduru